Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isobutyl cyanoacrylate is a medical-grade tissue adhesive and surgical glue. It is a cyanoacrylate ester that undergoes rapid polymerization upon contact with moisture or ionic surfaces (such as blood or tissue fluids), forming a strong physical bond that seals wounds and joins tissues. It is valued for its waterproof and bacteriostatic properties, which aid in surgical wound closure and the prevention of infection. While historically used in various surgical applications, including the repair of urethrocutaneous fistulas (UCF) and the embolization of vascular malformations, it is chemically distinct from other cyanoacrylates like n-butyl or isoamyl cyanoacrylate. Notably, the clinical trial context provided (NCT04876976) by Ain Shams University evaluates the related compound **isoamyl 2-cyanoacrylate** (Amident) as an interposition layer in UCF repair following hypospadias surgery, rather than the isobutyl derivative specified in the input name.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isobutyl cyanoacrylate.